Toward superhuman SARS-CoV-2 immunity?

Nat Med. 2021 Jan;27(1):5-6. doi: 10.1038/s41591-020-01180-x.

Authors

Dennis R Burton^{1

2}, Eric J Topol^{3

4}

Affiliations

¹ The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
² Ragon Institute of MGH, Harvard and MIT, Cambridge, MA, USA. burton@scripps.edu.
³ The Scripps Research Institute, La Jolla, CA, USA. etopol@scripps.edu.
⁴ Scripps Translational Research Institute, La Jolla, CA, USA. etopol@scripps.edu.

PMID: 33257892
DOI: 10.1038/s41591-020-01180-x

No abstract available

Publication types

Letter

MeSH terms

Animals
Antibody Formation*
COVID-19 Vaccines / immunology*
Humans
Immunity, Cellular
Infections / immunology
Infections / microbiology
Infections / virology
SARS-CoV-2 / immunology
Vaccines / immunology

Substances

COVID-19 Vaccines
Vaccines